XPO Other Non-Current Liabilities decreased by 13.0% to $300.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $292.00M to $300.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -2.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $450.00M | $366.00M | $272.00M | $311.00M | $310.00M | $306.00M | $259.00M | $264.00M | $264.00M | $262.00M | $285.00M | $297.00M | $294.00M | $303.00M | $283.00M | $292.00M | $329.00M | $338.00M | $345.00M | $300.00M |
| QoQ Change | — | -18.7% | -25.7% | +14.3% | -0.3% | -1.3% | -15.4% | +1.9% | +0.0% | -0.8% | +8.8% | +4.2% | -1.0% | +3.1% | -6.6% | +3.2% | +12.7% | +2.7% | +2.1% | -13.0% |
| YoY Change | — | — | — | — | -31.1% | -16.4% | -4.8% | -15.1% | -14.8% | -14.4% | +10.0% | +12.5% | +11.4% | +15.6% | -0.7% | -1.7% | +11.9% | +11.6% | +21.9% | +2.7% |